Photochemistry Creates Drug-Trapping Nanoparticles

Oct 09, 2006

Many of the most potent anticancer agents are poorly soluble in water, presenting a challenge for medicinal chemists who must develop methods of delivering these drugs in the watery environment of the human body. Nanoparticles appear to be perfectly suited to this task, and indeed, numerous research groups are developing nanoparticles specifically for delivering water-insoluble drugs to tumors.

One such team, led by Jeffrey Hubbell, Ph.D., at the École Polytechnique Fédérale de Lausanne (EPFL), in Switzerland, has developed a method that uses light to create a well-defined polymeric nanoparticle with internal spaces that can provide a friendly environment to water-insoluble drugs and channels through which the entrapped drugs can escape into malignant cells. The results of this effort appear in the European Journal of Pharmaceutical Sciences.

The investigators created these nanoparticles from two different polymers that crosslink to each other when exposed to light from an argon laser for one hour. They then added the nanoparticles to a solution of doxorubicin and evaporated the solvent used to dissolve the anticancer drug. Nearly half of the drug in solution became encapsulated within the nanoparticles. The researchers note that the resulting nanoparticles contain a protein-repelling surface coating that should result in favorable pharmacokinetic behavior.

Experiments to test the drug-release characteristics of these nanoparticles showed that maximum release occurred at approximately eight hours and then remained close to that level for a week. The data imply that release occurs through a diffusion mechanism, that is, drug travels through channels in the nanoparticle to the nanoparticle surface, as opposed to a disintegration mechanism in which the nanoparticle falls apart and releases drug.

This work is detailed in a paper titled, “Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles.” Investigators from the University of Zurich, in Switzerland, and the University of Manchester, in the UK, also participated in this study. An abstract of this paper is available through PubMed.

Source: National Cancer Institute

Explore further: Molecular beacons shine light on how cells 'crawl'

add to favorites email to friend print save as pdf

Related Stories

US official: Auto safety agency under review

11 hours ago

Transportation officials are reviewing the "safety culture" of the U.S. agency that oversees auto recalls, a senior Obama administration official said Friday. The National Highway Traffic Safety Administration has been criticized ...

Out-of-patience investors sell off Amazon

11 hours ago

Amazon has long acted like an ideal customer on its own website: a freewheeling big spender with no worries about balancing a checkbook. Investors confident in founder and CEO Jeff Bezos' invest-and-expand ...

Ebola.com domain sold for big payout

11 hours ago

The owners of the website Ebola.com have scored a big payday with the outbreak of the epidemic, selling the domain for more than $200,000 in cash and stock.

Recommended for you

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0